2013-10-23 14:34:52 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to GemVax Technology Co Ltd (41590) and produced a report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering GemVax Technology Co Ltd (41590). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential GemVax Technology Co Ltd investor.
Report Summary: GemVax Technology Co Ltd is an above average quality company with a neutral outlook. GemVax Technology Co Ltd has medium business growth and is run by efficient management. The trend in GemVax Technology Co Ltd fair value exchange rate against its closest rated-competitor, S Connect Co Ltd, has been depreciating over the past 2 weeks. When compared to its closest competitor, GemVax Technology Co Ltd shows similar overvaluation and is equally likely to outperform the market.
breaks down the Total StockMark into its three components - business, management and price, performing an in-depth analysis of GemVax Technology Co Ltd for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 20,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.